Open access
Open access
Powered by Google Translator Translator

Archives

Bioethics | Should clinical guidelines incorporate cost pathways for persons with financial hardship?

28 Feb, 2021 | 20:54h | UTC

Should Clinical Guidelines Incorporate Cost Pathways for Persons With Financial Hardship? – AMA Journal of Ethics

 


Joint Statement: Hydroxychloroquine use with respect to retinal toxicity

28 Feb, 2021 | 20:41h | UTC

ACR, AAD, RDS, and AAO 2020 Joint Statement on Hydroxychloroquine Use with Respect to Retinal Toxicity – Arthritis & Rheumatism

Commentary: Societies Agree on Eye Safety for HCQ – MedPage Today (free registration required) AND ACR, medical societies reach consensus on hydroxychloroquine retinopathy – Healio (free registration required)

 

Commentary on Twitter

 


Systematic Review: Cardiovascular Effects of Medical Marijuana

28 Feb, 2021 | 20:48h | UTC

Cardiovascular Effects of Medical Marijuana: A Systematic Review – The American Journal of Medicine

 


M-A: Adjuvant corticosteroids are effective in lowering the risk of kidney scarring in children with acute pyelonephritis

28 Feb, 2021 | 20:38h | UTC

Adjuvant corticosteroids for prevention of kidney scarring in children with acute pyelonephritis: a systematic review and meta-analysis – Archives of Disease in Childhood (link to abstract – $ for full-text)

 


U.S. Guidelines panel recommendation for long-acting injectable antiretroviral regimen in adults and adolescents with HIV

28 Feb, 2021 | 20:34h | UTC

HHS Adults and Adolescents Antiretroviral Guidelines Panel Recommendation for the Long-Acting Injectable Antiretroviral Regimen of Cabotegravir and Rilpivirine – HIV.gov

What’s New in the Guidelines? Panel’s Recommendation for Long-Acting Injectable Cabotegravir and Rilpivirine in Persons with HIV

 


Indian Guidelines for pediatric skin care in neonates, infants, and children

28 Feb, 2021 | 20:37h | UTC

Indian Academy of Pediatrics Guidelines for Pediatric Skin Care

 


CDC studies on superspreading events at fitness facilities

26 Feb, 2021 | 08:44h | UTC

Study 1: COVID-19 Outbreak Among Attendees of an Exercise Facility — Chicago, Illinois, August–September 2020 – CDC Morbidity and Mortality Weekly Report

Study 2: Community Transmission of SARS-CoV-2 at Three Fitness Facilities — Hawaii, June–July 2020 – CDC Morbidity and Mortality Weekly Report

Commentaries: Going maskless is a key factor in Covid-19 outbreaks at gyms, studies say – CNN AND A Chicago gym saw dozens of COVID-19 cases after infected people attended HIIT classes without masks – Insider

 


Conflicting results from 2 randomized trials testing Tocilizumab for Covid-19

26 Feb, 2021 | 08:48h | UTC

Study 1: Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia – New England Journal of Medicine

Study 2: Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – New England Journal of Medicine

Editorial: Interleukin-6 Receptor Inhibition in Covid-19 — Cooling the Inflammatory Soup – New England Journal of Medicine

 

Commentary on Twitter

 


PRO-CON Debate: Are Carbapenems necessary for all infections caused by ceftriaxone-resistant Enterobacterales?

28 Feb, 2021 | 20:43h | UTC

PRO: Carbapenems should be used for ALL infections caused by ceftriaxone-resistant Enterobacterales – JAC-Antimicrobial Resistance

CON: Carbapenems are NOT necessary for all infections caused by ceftriaxone-resistant Enterobacterales – JAC-Antimicrobial Resistance

Editorial: Navigating treatment approaches for presumed ESBL-producing infections

 

Commentary on Twitter (thread – click for more)

 


WHO Report: Preparing for Long COVID 2021

26 Feb, 2021 | 08:46h | UTC

In the wake of the pandemic: preparing for Long COVID (2021) – World Health Organization

News release: New policy brief calls on decision-makers to support patients as 1 in 10 report symptoms of “long COVID” – World Health Organization

Commentaries: Long COVID sufferer still has disease’s debilitating symptoms nearly a year after first falling ill – EuroNews AND Debilitating ‘long-COVID’ may have severe health, social impacts: WHO – Reuters

Related: Dr. Fauci says new data suggests ‘long’ Covid symptoms can last up to 9 months – CNBC

 


New protocol tested SARS-CoV-2 positivity on day 9 among quarantined student contacts of confirmed cases, resulting in safe reduction in loss of instructional time

26 Feb, 2021 | 08:42h | UTC

SARS-CoV-2 Positivity on or After 9 Days Among Quarantined Student Contacts of Confirmed Cases – JAMA

Commentary: Is the CDC 10-day COVID-19 quarantine guideline enough? – News Medical

 

Commentary on Twitter

 


Differences in characteristics and outcomes of children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) vs. severe acute COVID-19

26 Feb, 2021 | 08:43h | UTC

Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 – JAMA

Commentary: Studies help discern severe COVID from related kids’ syndrome – CIDRAP

 

Commentary on Twitter

 


Real-world data confirms Pfizer-BioNTech vaccine effectiveness

25 Feb, 2021 | 09:09h | UTC

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting – New England Journal of Medicine

Audio Interview: The Real-World Effectiveness of Covid-19 Vaccination – New England Journal of Medicine

Commentaries: Real-world trial of Pfizer COVID vaccine finds high 2-dose, good 1-dose protection – CIDRAP AND Pfizer-BioNTech vaccine performs as well in the real world as in clinical trials, new study concludes – STAT AND In boost for COVID-19 battle, Pfizer vaccine found 94% effective in real world – Reuters AND Expert reaction to NEJM paper on Pfizer-BioNTech vaccine roll-out in Israel and COVID-19 outcomes – Science Media Centre

 

Commentary on Twitter (thread – click for more)

 


Study finds increased COVID-19 mortality among adults with Down syndrome

26 Feb, 2021 | 08:39h | UTC

Medical vulnerability of individuals with down syndrome to severe COVID-19 – data from the trisomy 21 research society and the UK ISARIC4C survey – EClinicalMedicine

Commentaries: Adults with Down syndrome 3 times more likely to die of COVID, study finds – CIDRAP AND International study finds increased COVID-19 mortality among adults with Down syndrome – Case Western Reserve University

Related: COVID-19 is 10 times deadlier for people with Down syndrome, raising calls for early vaccination – Science (a few articles per month are free)

 


COVID-19 hospitalizations attributable to cardiometabolic conditions

26 Feb, 2021 | 08:40h | UTC

Coronavirus Disease 2019 Hospitalizations Attributable to Cardiometabolic Conditions in the United States: A Comparative Risk Assessment Analysis – Journal of the American Heart Association

Commentary: Study estimates two-thirds of COVID-19 hospitalizations due to four conditions – Tufts University

 

Commentary on Twitter

https://twitter.com/Dmozaffarian/status/1364993823370338312

 


Opinion – Catching COVID from surfaces is very unlikely. So perhaps we can ease up on the disinfecting

26 Feb, 2021 | 08:38h | UTC

Catching COVID from surfaces is very unlikely. So perhaps we can ease up on the disinfecting – The Conversation

Related: Coronavirus is in the air — there’s too much focus on surfaces – Nature AND COVID-19 rarely spreads through surfaces. So why are we still deep cleaning? – Nature

 


Ghana receives first historic shipment of COVID-19 vaccinations from international COVAX facility

25 Feb, 2021 | 09:12h | UTC

Ghana receives first historic shipment of COVID-19 vaccinations from international COVAX facility – UN News

See also: Ghana becomes recipient of historic first shipment of COVAX vaccines – World Health Organization

Commentaries: Covax vaccine-sharing scheme delivers first doses to Ghana – BBC AND Covax delivers first Covid vaccines in ‘momentous occasion’ – The Guardian AND COVAX delivers its first vaccine shots with shipment to Ghana – Reuters

 


Cohort study: A single conventional Troponin combined with HEART score may be as good as serial measurements for safe discharge of patients with chest pain in the ED

26 Feb, 2021 | 08:32h | UTC

Single vs Serial Measurements of Cardiac Troponin Level in the Evaluation of Patients in the Emergency Department With Suspected Acute Myocardial Infarction – JAMA Network Open

Editorial: Troponin Testing in the Emergency Department—When 2 Become 1

Commentary: Single Troponin Test May Be Enough for Safe Discharge of Chest Pain Patients – TCTMD

 


RCT: Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years

26 Feb, 2021 | 08:34h | UTC

Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai – The BMJ

Commentaries: The story of the Mumbai breast screening study – The BMJ Opinion

 

 


CAR T-cell therapy produces deep, sustained remissions in patients with relapsed myeloma

26 Feb, 2021 | 08:31h | UTC

CAR T-cell therapy produces deep, sustained remissions in patients with relapsed myeloma – Dana-Farber Cancer Institute

Original study: Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma – New England Journal of Medicine

 


Editorial: Five principles for the intelligent use of AI in medical imaging

26 Feb, 2021 | 08:29h | UTC

Five principles for the intelligent use of AI in medical imaging – Intensive Care Medicine

 

Commentary on Twitter

 


Integrated palliative and oncology care for patients receiving treatment for acute myeloid leukemia

26 Feb, 2021 | 08:25h | UTC

Integrated Palliative and Oncology Care for Patients Receiving Treatment for Acute Myeloid Leukemia – The ASCO Post

Original article: Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia: A Randomized Clinical Trial – JAMA Oncology (link to abstract – $ for full-text)

 


Decreasing patient-reported burden of treatment: A systematic review of quantitative interventional studies

26 Feb, 2021 | 08:21h | UTC

Decreasing patient-reported burden of treatment: A systematic review of quantitative interventional studies – PLOS One

 


Phase 2 trial: Muscarinic cholinergic receptor agonist and peripheral antagonist for schizophrenia

26 Feb, 2021 | 08:30h | UTC

Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Phase II Results Promising for New Schizophrenia Drug Combo – MedPage Today

 


Systematic Review: Insufficient evidence to decide whether surgical intervention is beneficial or harmful for the early management of Bell’s palsy

26 Feb, 2021 | 08:20h | UTC

Surgical interventions for the early management of Bell’s palsy – Cochrane Library

Summary: Surgical operation for Bell’s palsy (idiopathic facial paralysis) – Cochrane Library

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.